FDA Issues Draft Guidance on Use of Decentralized Clinical Trials

Leave a Comment / adverse events, clinical trials, DCTs, Digital Health, informed consent, investigational products, Medical Device, MedTech, Quality/Regulatory, RC - Medtech Regulatory Resource Center / By

FDA Issues Draft Guidance on Use of Decentralized Clinical Trials     The FDA has published a new draft guidance on the use of decentralized clinical trials (DCT), which it defines as a clinical trial where some or all of the trial-related activities occur at locations other than traditional clinical trial sites. “Decentralized Clinical Trials for …

FDA Issues Draft Guidance on Use of Decentralized Clinical Trials Read More »